Heterocyclic inhibitors of stearoyl-CoA desaturase

Details for Australian Patent Application No. 2009216769 (hide)

Owner Novartis AG Xenon Pharmaceuticals Inc.

Inventors Zhang, Zaihui; Fu, Jianmin; Jia, Qi; Kodumuru, Vishnumurthy; Dales, Natalie; Hou, Duanjie; Sun, Shaoyi; Pokrovskaia, Natalia; Chowdhury, Sultan; Fonarev, Julia

Agent Davies Collison Cave

Pub. Number AU-A-2009216769

PCT Pub. Number WO2009/103739

Priority 61/030,137 20.02.08 US

Filing date 18 February 2009

Wipo publication date 27 August 2009

International Classifications

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/103739 Priority application(s): WO2009/103739

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009216777-Double-layer multiple-coil supercapacitor

2009216764-Solar cell system with encapsulant